drugset / Trial / NCT05672212
Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease
RandomizedParallel-groupOpen-labelOther
Summary
Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.
Timeline
- Start
- 2023-01-04
- Primary completion
- 2025-01-04
- Completion
- 2025-01-04
Outcome
Met primary endpoint
paper The Analgesia Nociception Index group showed lower intra-operative sufentanil consumption PMID 38832435 ↗
paper mean difference, -0.09; 95% confidence interval, -0.19 to 0.00; P = 0.049 PMID 38832435 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sufentanil | Other / unclassified | — | Other |
Indications
No indication recorded.